These findings also suggest that glucose metabolism-related myocardial fibrosis may bring out differential targeting effects of miR-34a, while the mechanisms by whether exercise or exercise-induced irisin can execute the mitigation of miR-34a-mediated myocardial fibrosis are unknown. The gene discussed is FNDC5; the disease is Myocardial fibrosis.